Modern ways of doxicycline delivery and prospects of application in pharmacy

Currently, the global increase in resistance of pathogens to widely used antibiotics requires a return to the practice of using some classic drugs with preserved activity, finding new ways and directions of delivery of antibiotics to the locations of pathogenic microorganisms and the use of antimicr...

Full description

Bibliographic Details
Main Authors: O. O. Saliy, Y. V. Sachenko, T. A. Palchevska, V. V. Strashnyi
Format: Article
Language:Ukrainian
Published: The State Expert Center of the Ministry of Health of Ukraine 2022-08-01
Series:Фармацевтичний журнал
Subjects:
Online Access:https://pharmj.org.ua/index.php/journal/article/view/1307/1225
_version_ 1797669564220178432
author O. O. Saliy
Y. V. Sachenko
T. A. Palchevska
V. V. Strashnyi
author_facet O. O. Saliy
Y. V. Sachenko
T. A. Palchevska
V. V. Strashnyi
author_sort O. O. Saliy
collection DOAJ
description Currently, the global increase in resistance of pathogens to widely used antibiotics requires a return to the practice of using some classic drugs with preserved activity, finding new ways and directions of delivery of antibiotics to the locations of pathogenic microorganisms and the use of antimicrobial drugs that are not yet resistant. Doxycycline refers to antimicrobial drugs that do not yet have widespread resistance. Numerous studies of doxycycline have now been described as enhancing therapeutic effects, including COVID-19-related diseases, and finding new delivery routes to limit systemic side effects associated with high doses and avoid antibiotic resistance. The aim of the work was to analyze modern ways of doxycycline delivery, to determine the prospects for use in pharmacy, to summarize and systematize data on its functional purpose in the development of drugs with specified pharmaco-technological parameters. It is established that in the Ukrainian pharmaceutical market the range of drugs based on doxycycline hyclate is represented only by solid oral dosage forms - tablets and capsules for immediate release, but in the global pharmaceutical market there are additional dosage forms that provide parenteral delivery of doxycycline and oral forms. suspensions, syrups, dispersed tablets and delayed-release dosage forms – tablets, capsules and granules, which are the basis for the development of domestic drugs based on doxycycline. Development of new dosage forms with modified DH, such as implants, aerosols, lyophilisate for solution for injection, development of new manufacturing technologies, selection of excipients and delivery systems can improve the pharmacological action of antibiotics by reducing the dose and frequency of administration, prolonged or controlled programming. , and expanding the range of therapeutic action. Doxycycline is promising in pharmaceutical practice for the treatment of COVID-19, both due to its ability to inhibit matrix metalloproteinases (MMPs) and antiviral activity, especially against Mycoplasma pneumoniae, which is a secondary bacterial cause of pneumonia during the COVID-19 pandemic.
first_indexed 2024-03-11T20:46:14Z
format Article
id doaj.art-4bf389523f284856a2a4468260736717
institution Directory Open Access Journal
issn 0367-3057
2617-9628
language Ukrainian
last_indexed 2024-03-11T20:46:14Z
publishDate 2022-08-01
publisher The State Expert Center of the Ministry of Health of Ukraine
record_format Article
series Фармацевтичний журнал
spelling doaj.art-4bf389523f284856a2a44682607367172023-10-01T11:11:10ZukrThe State Expert Center of the Ministry of Health of UkraineФармацевтичний журнал0367-30572617-96282022-08-014506110.32352/0367-3057.4.22.06Modern ways of doxicycline delivery and prospects of application in pharmacyO. O. Saliy0https://orcid.org/0000-0001-7103-2083Y. V. Sachenko1https://orcid.org/0000-0002-9918-7009T. A. Palchevska 2https://orcid.org/0000-0002-7101-4317V. V. Strashnyi3https://orcid.org/0000-0002-9188-1821Kyiv National University of Technologies and DesignKyiv National University of Technologies and DesignKyiv National University of Technologies and DesignKyiv National University of Technologies and DesignCurrently, the global increase in resistance of pathogens to widely used antibiotics requires a return to the practice of using some classic drugs with preserved activity, finding new ways and directions of delivery of antibiotics to the locations of pathogenic microorganisms and the use of antimicrobial drugs that are not yet resistant. Doxycycline refers to antimicrobial drugs that do not yet have widespread resistance. Numerous studies of doxycycline have now been described as enhancing therapeutic effects, including COVID-19-related diseases, and finding new delivery routes to limit systemic side effects associated with high doses and avoid antibiotic resistance. The aim of the work was to analyze modern ways of doxycycline delivery, to determine the prospects for use in pharmacy, to summarize and systematize data on its functional purpose in the development of drugs with specified pharmaco-technological parameters. It is established that in the Ukrainian pharmaceutical market the range of drugs based on doxycycline hyclate is represented only by solid oral dosage forms - tablets and capsules for immediate release, but in the global pharmaceutical market there are additional dosage forms that provide parenteral delivery of doxycycline and oral forms. suspensions, syrups, dispersed tablets and delayed-release dosage forms – tablets, capsules and granules, which are the basis for the development of domestic drugs based on doxycycline. Development of new dosage forms with modified DH, such as implants, aerosols, lyophilisate for solution for injection, development of new manufacturing technologies, selection of excipients and delivery systems can improve the pharmacological action of antibiotics by reducing the dose and frequency of administration, prolonged or controlled programming. , and expanding the range of therapeutic action. Doxycycline is promising in pharmaceutical practice for the treatment of COVID-19, both due to its ability to inhibit matrix metalloproteinases (MMPs) and antiviral activity, especially against Mycoplasma pneumoniae, which is a secondary bacterial cause of pneumonia during the COVID-19 pandemic.https://pharmj.org.ua/index.php/journal/article/view/1307/1225doxycycline hyclatedrug deliverydosage formssustained drug releasecontrolled release
spellingShingle O. O. Saliy
Y. V. Sachenko
T. A. Palchevska
V. V. Strashnyi
Modern ways of doxicycline delivery and prospects of application in pharmacy
Фармацевтичний журнал
doxycycline hyclate
drug delivery
dosage forms
sustained drug release
controlled release
title Modern ways of doxicycline delivery and prospects of application in pharmacy
title_full Modern ways of doxicycline delivery and prospects of application in pharmacy
title_fullStr Modern ways of doxicycline delivery and prospects of application in pharmacy
title_full_unstemmed Modern ways of doxicycline delivery and prospects of application in pharmacy
title_short Modern ways of doxicycline delivery and prospects of application in pharmacy
title_sort modern ways of doxicycline delivery and prospects of application in pharmacy
topic doxycycline hyclate
drug delivery
dosage forms
sustained drug release
controlled release
url https://pharmj.org.ua/index.php/journal/article/view/1307/1225
work_keys_str_mv AT oosaliy modernwaysofdoxicyclinedeliveryandprospectsofapplicationinpharmacy
AT yvsachenko modernwaysofdoxicyclinedeliveryandprospectsofapplicationinpharmacy
AT tapalchevska modernwaysofdoxicyclinedeliveryandprospectsofapplicationinpharmacy
AT vvstrashnyi modernwaysofdoxicyclinedeliveryandprospectsofapplicationinpharmacy